Shane Kelly is currently the Associate Director of Medical Safety Science at Gilead Sciences, where they focus on patient safety and evidence-based decision-making. Their extensive experience in the pharmaceutical industry includes roles such as Pharmacovigilance Associate at Alliance Pharmaceuticals and Consultant at Eli Lilly and Company. Shane holds a Ph.D. in Oncology from the University of Cambridge and has a strong academic background complemented by various certifications in pharmacovigilance. They are recognized for their strong communication skills and leadership in cross-functional safety management forums.
This person is not in the org chart
This person is not in any teams
This person is not in any offices